Patents by Inventor Roberto Zoncu

Roberto Zoncu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compounds for targeted autophagy
    Patent number: 11666661
    Abstract: Provided herein, inter alia, are methods and compounds for targeted autophagy.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: June 6, 2023
    Assignees: The Regents of the University of California, Frontier Medicines Corporation
    Inventors: Daniel K. Nomura, Roberto Zoncu, Carl Ward, Sin Ki Fung, Chris Kumar Varma, Benjamin Fontaine
  • mTORC1 modulators
    Patent number: 10807951
    Abstract: Provided herein, inter alia, are methods and compounds for inhibiting mTORC1 and for treating diseases associated with mTORC1 activity.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: October 20, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Daniel K. Nomura, Roberto Zoncu, Allison M. Roberts, Kelvin F. Cho, Yik Sham Clive Chung, Hijai Shin, Benjamin Croze
  • METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY
    Publication number: 20190290778
    Abstract: Provided herein, inter alia, are methods and compounds for targeted autophagy.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 26, 2019
    Inventors: Daniel K. Nomura, Roberto Zoncu, Carl Ward, Sin Ki Fung, Chris Kumar Varma, Benjamin Fontaine
  • mTORC1 MODULATORS
    Publication number: 20190112268
    Abstract: Provided herein, inter alia, are methods and compounds for inhibiting mTORC1 and for treating diseases associated with mTORC1 activity.
    Type: Application
    Filed: October 12, 2018
    Publication date: April 18, 2019
    Inventors: Daniel K. Nomura, Roberto Zoncu, Allison M. Rpberts, Kelvin F. Cho, Yik Sham Clive Chung, Hijai Shin, Benjamin Croze
  • mTORC1 MODULATION BY AMINO ACIDS AND USES THEREOF
    Publication number: 20170027897
    Abstract: Disclosed herein are methods for modulating mTORC1 activation in cells or a subject, and related compositions, kits, and agents for use in those methods. Also disclosed is the treatment of diseases and conditions characterized by decreased mTORC1 activation.
    Type: Application
    Filed: October 23, 2014
    Publication date: February 2, 2017
    Inventors: Shuyu Wang, William Comb, Alejo Efeyan, Roberto Zoncu, David M. Sabatini